rs 67333 has been researched along with amyloid beta-peptides in 1 studies
| Studies (rs 67333) | Trials (rs 67333) | Recent Studies (post-2010) (rs 67333) | Studies (amyloid beta-peptides) | Trials (amyloid beta-peptides) | Recent Studies (post-2010) (amyloid beta-peptides) |
|---|---|---|---|---|---|
| 63 | 0 | 34 | 3,257 | 48 | 1,626 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, S; Hu, Y | 1 |
1 other study(ies) available for rs 67333 and amyloid beta-peptides
| Article | Year |
|---|---|
Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Male; Mice; Mice, Transgenic; Nerve Degeneration; Neurons; Neuroprotective Agents; Peptide Fragments; Piperidines; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Agonists; Serotonin Receptor Agonists; Synaptic Transmission; Treatment Outcome | 2007 |